These results reveal TFRC as a key effector through which NEDD4L regulates ferroptosis and suggest targeting the NEDD4L-TFRC interaction may have therapeutic potential for mitigating iron-mediated brain injury after stroke. The gene discussed is NEDD4L; the disease is stroke disorder.